Option Care Health, Inc. (NASDAQ:OPCH) Receives $35.50 Average Target Price from Analysts

Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight analysts that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $35.50.

OPCH has been the topic of several analyst reports. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JMP Securities reiterated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research note on Wednesday, June 18th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio raised its position in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the last quarter. US Bancorp DE boosted its stake in shares of Option Care Health by 5.0% in the first quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after purchasing an additional 393 shares during the period. Sheets Smith Wealth Management boosted its stake in shares of Option Care Health by 1.9% in the second quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company's stock valued at $810,000 after purchasing an additional 457 shares during the period. State of Michigan Retirement System boosted its stake in Option Care Health by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock valued at $1,425,000 after acquiring an additional 500 shares during the last quarter. Finally, Louisiana State Employees Retirement System boosted its stake in Option Care Health by 1.1% during the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock valued at $1,667,000 after acquiring an additional 500 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $0.07 during trading on Friday, reaching $30.75. 1,194,973 shares of the stock traded hands, compared to its average volume of 1,846,801. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. Option Care Health has a 52-week low of $21.39 and a 52-week high of $35.53. The business has a fifty day simple moving average of $31.76 and a two-hundred day simple moving average of $31.53. The company has a market capitalization of $5.03 billion, a price-to-earnings ratio of 24.82, a P/E/G ratio of 1.81 and a beta of 0.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. Option Care Health's revenue was up 16.3% compared to the same quarter last year. During the same period last year, the company posted $0.26 earnings per share. Sell-side analysts expect that Option Care Health will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.